Clinical trial
Bipolar Disorder Study for Men and Women
NCT00056277 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00056277 |
|---|---|
| Title | Bipolar Disorder Study for Men and Women |
| Official title | Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 150 |
| Start date | Feb 27, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Dec 14, 2005 |
| First posted | Mar 11, 2003 |
| Last update posted | Apr 7, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: